j.vandermolen
TL3 Regular · Catania, IT
Clinician. Posts general information only, and says so every time.
Joined 16 July 2024 · last posted 1d · groups: clinicians
124 posts, newest first. Showing up to 150.
-
Reading order for a first week here, and what to skip until later — what changed since Replied, post #90 · Start Here › Welcome · 27 Jul 2026 · 1 like Something worth flagging about Reading order: the strongest-sounding claims in this thread are the ones with no source attached, which is the usual pattern and not a…
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #75 · Compounds › Retatrutide · 19 Jul 2026 · 1 like What we do not know about retatrutide, listed explicitly: long-term safety, real-world response rates, the dose response in diverse populations, whether the heart-rate…
-
Why the Start Here categories exist, and what they are not for Replied, post #10 · Start Here › Welcome · 18 Jul 2026 · 3 likes I read the earlier replies on Start twice before writing this, because I had assumed the opposite and wanted to be sure I was disagreeing with what was said rather than…
-
Pooling trials with different estimands Replied, post #95 · Evidence › Meta-analyses · 13 Jul 2026 · 0 likes Answering the question post #91 raises rather than the one it answers. My position on pooling trials with different estimands is current rather than settled. I have…
-
Reused chromatograms across lots: how to spot it Replied, post #57 · Analytics › COA interpretation · 13 Jul 2026 · 10 likes Since reused chromatograms across lots keeps coming up, it should probably be a maintained page rather than a recurring thread. I am happy to draft it if someone with…
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #76 · Access › International · 13 Jul 2026 · 6 likes Clear enough that I do not think I have a follow-up, which is unusual.
-
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #58 · Compounds › Repair & healing peptides · 12 Jul 2026 · 3 likes For anyone arriving from search engines: this subcategory discusses published preclinical work and the absence of published clinical work. It does not endorse or…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #68 · Analytics › Impurities & related substances · 11 Jul 2026 · 14 likes Understood, and I withdraw the assumption I opened with.
-
Prior authorisation: what the criteria usually require — a second dataset Replied, post #11 · Access › Insurance & coverage · 9 Jul 2026 · 6 likes Nothing here is legal or medical advice, and appeal processes differ enough by jurisdiction and payer that specifics do not transfer. I would be glad to be shown a…
-
AOD-9604 and the fragment hypothesis, revisited — does this still hold? Replied, post #11 · Compounds › Other compounds · 8 Jul 2026 · 3 likes Fragment compounds — where the material is part of a larger natural protein — should be identified by sequence rather than by name, because the naming in this space is…
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #13 · Practice › Interactions · 5 Jul 2026 · 0 likes I read post #11 twice before replying, because I had assumed the opposite. The number people quote for Antibiotics is a central estimate presented without its interval,…
-
Restarting after a long gap: what the labelling implies Replied, post #12 · Practice › Dosing & titration · 5 Jul 2026 · 0 likes Narrowing post #9, because the general version has more than one answer. Concentration and dose get conflated constantly in this subcategory. Changing how much diluent…
-
Private prescribing in the UK: what is actually involved Replied, post #50 · Regional › UK & Ireland · 28 Jun 2026 · 0 likes I read post #48 twice before replying, because I had assumed the opposite. Summarising the private prescribing thread so far, since it is long and the answer is buried:…
-
Personal or family history of medullary thyroid carcinoma Replied, post #21 · Safety › Contraindications · 27 Jun 2026 · 13 likes History of pancreatitis: these compounds can rarely trigger pancreatitis. History of pancreatitis increases relative risk. That is a relative contraindication, not…
-
Personal or family history of medullary thyroid carcinoma Replied, post #2 · Safety › Contraindications · 20 Jun 2026 · 7 likes Medullary thyroid carcinoma (personal or family history) or multiple endocrine neoplasia type 2: absolute contraindication. The rodent preclinical signal is real enough…
-
An appeal that succeeded, with the letter structure Replied, post #9 · Access › Insurance & coverage · 17 Jun 2026 · 27 likes This follows post #6 rather than contradicting it. My experience of appeal contradicts the reply above. I am posting it as a data point rather than as a refutation,…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #40 · Evidence › Journal club · 12 Jun 2026 · 0 likes This follows post #37 rather than contradicting it. STEP 1 looks different depending on whether you are reading the primary literature or the summaries of it, and the…
-
Primary endpoint hierarchies and why order matters — one year on Replied, post #13 · Evidence › Trials · 12 Jun 2026 · 0 likes Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it truly random or could someone predict the next assignment),…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #98 · Practice › Reconstitution · 9 Jun 2026 · 0 likes This follows post #96 rather than contradicting it. Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into…
-
Reading a trial's population section before its results Replied, post #99 · Evidence › Trials · 8 Jun 2026 · 18 likes I had written a reply contradicting post #95 and deleted it. Here is what survived. Nothing in a trial report is medical advice about an individual, and the gap between…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #73 · Practice › Reconstitution · 26 May 2026 · 0 likes Coming back to post #71, because the follow-up matters more than the original answer. Swirling until fully clear before drawing is worth the extra minute. A partially…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #136 · Compounds › Tirzepatide · 23 May 2026 · 15 likes The 2.5 mg starting dose is a tolerance step and not a therapeutic one. Judging efficacy at that dose is the single commonest reasoning error in this subcategory.
-
The anatomy of a question that gets answered within an hour Replied, post #43 · Start Here › How to Ask · 12 May 2026 · 18 likes Coming back to post #41, because the follow-up matters more than the original answer. A photograph of a vial is rarely useful and a photograph of a document usually is.…
-
Second pass at: Leak-back after withdrawal and whether you lost a meaningful dose Replied, post #13 · Practice › Administration · 9 May 2026 · 12 likes I would keep Leak-back and the decision it usually gets used for separate in this thread. They are related and they are not the same question, and merging them is why…
-
A checklist for reading a certificate in under two minutes Replied, post #14 · Analytics › COA interpretation · 2 May 2026 · 1 like Good question, well framed, and I would like to see it answered properly.
-
[2026 update] Composite endpoints and the component doing the work Replied, post #87 · Evidence › Trials · 26 Apr 2026 · 4 likes Confirming post #85 from a second method, which matters more than confirming it from a second person. Absolute numbers, not just relative: a 30% relative reduction…
-
Follow-up: State-level differences that actually matter Replied, post #95 · Regional › North America · 9 Apr 2026 · 8 likes Adding the measurement that post #92 says would settle it. The claim about State-level differences upthread is stronger than its source supports. I have read the…
-
About the UK & Ireland category Replied, post #3 · Regional › UK & Ireland · 7 Apr 2026 · 19 likes As a member rather than staff: the most useful thing I did when I started reading this category was to work through the tag pages rather than the topic list. The topic…
-
The "under review" status pill and when a moderator applies it Replied, post #56 · Evidence › Preprints · 5 Apr 2026 · 22 likes Building on post #53 rather than restating it. Reading a preprint properly means doing some of the reviewer's job: methods first, then whether the analysis matches the…
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #6 · Analytics › Mass spectrometry · 13 Mar 2026 · 0 likes I had written a reply contradicting post #4 and deleted it. Here is what survived. I would be cautious about generalising from the Charge states example above. It is a…
-
The lowest dose that does anything: is that a real question? Replied, post #88 · Practice › Dosing & titration · 7 Mar 2026 · 3 likes I had written a reply contradicting post #84 and deleted it. Here is what survived. I would be cautious about generalising from the lowest dose example above. It is a…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #126 · Practice › Interactions · 6 Mar 2026 · 5 likes SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern.
-
About the Storage & stability category Replied, post #3 · Practice › Storage & stability · 2 Mar 2026 · 5 likes As a member rather than staff: the most useful thing I did when I started reading this category was to work through the tag pages rather than the topic list. The topic…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #135 · Analytics › COA interpretation · 18 Feb 2026 · 15 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
-
Constipation management, with a dietitian's contribution Replied, post #31 · Practice › Side effects · 18 Feb 2026 · 2 likes Helpful, and easy to find again, which is half of what a good reply is.
-
[2026 update] What a purity-only report leaves out Replied, post #27 · Sourcing › Independent verification · 16 Feb 2026 · 12 likes The bit of purity-only that nobody enjoys is that the answer changes depending on what you are trying to decide with it. Say what the decision is and the thread will…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #27 · Practice › Dosing & titration · 16 Feb 2026 · 1 like Worth separating two things that post #25 runs together. Micro-titration: the concept of increments smaller than the labelled steps. It has no evidence base from trials…
-
Non-inferiority margins: how they are chosen and how they are abused — a second dataset Replied, post #30 · Evidence › Trials · 15 Feb 2026 · 20 likes Narrowing post #27, because the general version has more than one answer. Non-inferiority margins would be much easier to settle if anyone reported the denominator.…
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #88 · Documentation › Wiki requests · 14 Feb 2026 · 12 likes Narrowing post #87, because the general version has more than one answer. Authority and authorship: if you think a maintained page needs input from someone with…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #22 · Data & Tools › Datasets · 4 Feb 2026 · 7 likes Coming back to post #20, because the follow-up matters more than the original answer. Where a value is derived rather than measured, mark it. Derived columns get…
-
Second pass at: Submitting a sample: the process end to end Replied, post #6 · Sourcing › Independent verification · 3 Feb 2026 · 3 likes This follows post #4 rather than contradicting it. What would change my mind on Submitting a sample is a second dataset collected by someone with no stake in the first.…
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #14 · Practice › Administration · 28 Jan 2026 · 0 likes Where I part company with post #10, and it is a narrow parting. Needle length matters less than angle for subcutaneous delivery in most people. A short needle at ninety…
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #118 · Clinical › Special populations · 27 Jan 2026 · 12 likes Being outside the studied population does not mean a treatment is unsafe. It means the usual evidence is not available and the reasoning has to be explicit.
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #23 · Pharmacology › Pharmacokinetics · 24 Jan 2026 · 0 likes Area under the curve is the exposure measure that matters for most effects in this class. Peak concentration matters more for tolerability.
-
A 10 mg vial reconstituted three different ways, compared Started this topic · Practice › Reconstitution · 9 Jan 2026 · 14 likes Posting this under the heading it deserves: A 10 mg vial reconstituted three different ways, compared Everything below is what sits behind that. Something about 10 mg…
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #7 · Practice › Administration · 8 Jan 2026 · 0 likes On post #3 — agreed on the reasoning, with one qualification. If you have to inject at a different time of day than usual, that is a much smaller perturbation than it…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 — does this still hold? Replied, post #13 · Compounds › Cagrilintide & amylin analogues · 23 Dec 2025 · 0 likes Cagrilintide molecular characteristics: it is a synthetic amylin analogue, substituted to prevent the amyloidogenicity of human amylin. The sequence is short and…
-
Heterogeneity as information rather than as a nuisance Replied, post #34 · Evidence › Meta-analyses · 22 Dec 2025 · 6 likes On heterogeneity, the part that usually goes wrong is that the question is asked as though it has one answer. It has a range, and the width of the range is the…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #56 · Compounds › Tirzepatide · 8 Dec 2025 · 0 likes The GIP component: GIP receptor agonism is thought to amplify the GLP-1 effect on satiety and energy expenditure, but how much of tirzepatide's effect is that and how…
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #72 · Analytics › Home & field testing · 7 Dec 2025 · 0 likes The honest cost comparison is a home kit against a single independent submission. For most people the second answers the question and the first answers a different,…
-
Why one laboratory's 98.4% and another's 96.1% may not contradict Replied, post #32 · Analytics › Method validation · 27 Nov 2025 · 23 likes Range and working range are different things and a certificate rarely distinguishes them. The relevant one is the range over which this particular sample was measured.…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — a second dataset Replied, post #10 · Sourcing › Independent verification · 27 Nov 2025 · 0 likes Two sentences on Janoshik and then I will stop, because the rest is speculation and the thread is better without mine. What is documented is narrow. What is inferred…
-
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #96 · Compounds › Other compounds · 26 Nov 2025 · 25 likes A compound with no established assay is a compound where a certificate can say almost anything. That is not an accusation about anyone; it is a statement about what a…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #55 · Compounds › Oral incretins · 22 Nov 2025 · 9 likes Trial adherence in an oral trial with strict administration requirements is genuinely worse than trial-published data often suggests. That is why the exposure…
-
What a regulator's shortage notice actually authorises — what changed since Replied, post #17 · Sourcing › Regulatory · 8 Nov 2025 · 14 likes Taking post #16 at face value and following it one step further. Generic or biosimilar entry depends on patent and exclusivity positions that are jurisdiction-specific…
-
Guidelines revision: what changed and why — one year on Replied, post #30 · Meta › Announcements · 29 Oct 2025 · 7 likes On Guidelines revision, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.
-
Sleep tracking data and its considerable limitations Replied, post #117 · Wellbeing › Sleep · 28 Oct 2025 · 0 likes Where I part company with post #114, and it is a narrow parting. The documentation on sleep is better than this thread and I say that as someone who has posted in the…
-
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #74 · Practice › Reconstitution · 28 Oct 2025 · 0 likes Research-use-only material reconstituted at home is not a compounded sterile preparation and nothing about the procedure makes it one. Members describing what they do…
-
Deconvolution of a multiply charged envelope Replied, post #3 · Analytics › Mass spectrometry · 30 Sep 2025 · 0 likes Charge states observed: for semaglutide (4113.6 Da) the doubly charged ion appears at m/z ≈ 2057, triply charged at ≈ 1371, quadruply at ≈ 1029. Those are the positions…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #133 · Practice › Reconstitution · 26 Sep 2025 · 13 likes Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #59 · Lounge › Off topic · 26 Sep 2025 · 3 likes Newer drugs and mechanisms: when a new drug launches or a new mechanism is discovered, the Lounge is a place to discuss the news and speculate before hard data exists.
-
What pooling buys you and what it destroys Replied, post #25 · Evidence › Meta-analyses · 20 Sep 2025 · 23 likes Answering the question post #23 raises rather than the one it answers. Double extraction with disagreement resolution is standard and is worth checking for, because…
-
What this community means by "a source", in practical terms Replied, post #120 · Start Here › Welcome · 19 Sep 2025 · 11 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #144 · Practice › Storage & stability · 18 Sep 2025 · 7 likes A supplier stability statement tied to a named storage condition can be evaluated. One that says "store cool" cannot, and the difference between those two documents is…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #138 · Data & Tools › Datasets · 11 Sep 2025 · 2 likes One caution on Aggregated purity results across four: everything above assumes the underlying documentation is what it claims to be. That assumption is doing real work…
-
Are there stupid questions here? A staff answer, at length Replied, post #150 · Start Here › Welcome · 4 Sep 2025 · 26 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #63 · Evidence › Journal club · 31 Aug 2025 · 1 like Orforglipron phase 2 came up in a thread eighteen months ago and was answered well. I cannot find it, which is itself the problem, so here is the reconstruction.
-
Second pass at: LOD and LOQ: definitions people get wrong Replied, post #16 · Analytics › Method validation · 26 Aug 2025 · 0 likes Building on post #13 rather than restating it. The most useful reply I ever got about LOD and LOQ was a request to state my units. It sounds like pedantry and it has…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #114 · Compounds › Semaglutide · 11 Aug 2025 · 3 likes Adding the measurement that post #113 says would settle it. Albumin binding is not a unique structural feature and nothing in the class lacks it, but the reversibility…
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria — a… Replied, post #18 · Analytics › Method validation · 11 Aug 2025 · 13 likes Post #16 is the version of this I will quote in future. One addition. I keep a log for Specificity specifically because my memory of it turned out to be systematically…
-
When a preprint is the best available evidence and we say so Replied, post #30 · Evidence › Preprints · 6 Aug 2025 · 10 likes Thank you — that answers what I came here to find out.
-
Micronutrient status when intake falls substantially Replied, post #22 · Clinical › Bloodwork · 5 Aug 2025 · 0 likes On post #18 — agreed on the reasoning, with one qualification. Time of day: some biomarkers vary across the day. Cortisol in the morning differs from cortisol in the…
-
[2026 update] Comparing documentation quality across the directory, tabulated Started this topic · Sourcing › Vendor reports · 27 Jul 2025 · 7 likes On the subject in the title: Comparing documentation quality across the directory, tabulated Working notes rather than a conclusion. Structured question about…
-
What this community means by "a source", in practical terms Replied, post #42 · Start Here › Welcome · 21 Jul 2025 · 5 likes Thank you — that answers what I came here to find out.
-
Repeatability versus intermediate precision Replied, post #63 · Analytics › Method validation · 25 Jun 2025 · 0 likes An independent laboratory's method being different from the supplier's is not a discrepancy. It becomes one only when the results differ by more than both methods'…
-
Follow-up: Tracking intake honestly when appetite is absent Replied, post #89 · Nutrition & Training › Protein & intake · 14 Jun 2025 · 20 likes I read post #87 twice before replying, because I had assumed the opposite. Checked the Tracking intake claim against the primary source this morning. It survives, with…
-
Coming back to: Getting a referral rather than a refusal Replied, post #56 · Clinical › Prescriber conversations · 11 Jun 2025 · 0 likes Building on post #53 rather than restating it. If you have been doing something the prescriber does not know about, saying so is more useful than not. Clinicians here…
-
Sodium, potassium and magnesium when intake drops Replied, post #12 · Nutrition & Training › Hydration & electrolytes · 11 Jun 2025 · 5 likes Magnesium: deficiency during weight loss is common and symptoms (fatigue, muscle cramps) are nonspecific. Supplementation is inexpensive and low-risk if needed.
-
Coming back to: Lurking for two months before posting: was that the right call? Replied, post #2 · Start Here › Welcome · 10 Jun 2025 · 8 likes Trust levels accumulate over time and they give you access to small things like the ability to edit your own posts without a timestamp. They are not a status symbol and…
-
Shakes versus food: a pragmatic assessment — the long version Replied, post #42 · Nutrition & Training › Protein & intake · 1 Jun 2025 · 10 likes Where I part company with post #41, and it is a narrow parting. Where intake has fallen a long way, protein is usually the first thing to fall because it is the least…
-
A report I filed that turned out to be wrong, and the correction Replied, post #76 · Sourcing › Vendor reports · 29 May 2025 · 0 likes Reading back through, this was answered upthread and I missed it. My fault.
-
DXA precision and the least significant change for lean mass — the long version Replied, post #94 · Outcomes › Body composition · 25 May 2025 · 8 likes Post #91 answers the question as asked. The question underneath it is different. Where a scan disagrees with the mirror over a short period, the scan's precision limits…
-
Relative retention time as a better inter-laboratory comparator Replied, post #11 · Analytics › Method validation · 19 May 2025 · 5 likes Post #8 put the caveat in the right place and I want to underline it. An update on my earlier relative retention time post: the pattern held for another six weeks and…
-
DXA precision and the least significant change for lean mass — the long version Replied, post #48 · Outcomes › Body composition · 16 May 2025 · 14 likes DXA on the same machine with the same technician has a least significant change for lean mass of roughly a kilogram, sometimes more. Below that, two scans are the same…
-
Fibre intake when total intake falls, and the constipation link Replied, post #66 · Nutrition & Training › Protein & intake · 11 May 2025 · 0 likes Temperature and texture change what is tolerable for a lot of people during the first weeks, and that is worth experimenting with before concluding nothing works. Happy…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #90 · Evidence › Journal club · 21 Apr 2025 · 4 likes Everything in post #88 holds. The case it does not cover is the one I have. An update on my earlier STEP 1 post: the pattern held for another six weeks and then…
-
Counter-ion content and its effect on measured mass Replied, post #16 · Analytics › Mass spectrometry · 12 Apr 2025 · 2 likes A mass match establishes that the measured mass is consistent with the proposed composition. It does not establish purity, sequence order, or the absence of an isomer,…
-
Retatrutide dose escalation in the published trials Replied, post #95 · Compounds › Retatrutide · 6 Apr 2025 · 0 likes Duration is the other limitation. The published exposure is measured in months, and the questions people are actually asking are about years.
-
A well-designed study with a badly written abstract Replied, post #9 · Evidence › Study critique · 4 Apr 2025 · 5 likes Post #7 is right about the mechanism and I think understates the practical bit. Practical answer on well-designed study, since the theoretical one is upthread: do the…
-
Sequence verification for an obscure compound: how it is done Replied, post #4 · Compounds › Other compounds · 31 Mar 2025 · 9 likes AOD-9604 is a fragment of human growth hormone and has been discussed as a potential weight-loss agent based on theoretical mechanism. The fragment hypothesis — that…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #40 · Practice › Reconstitution · 29 Mar 2025 · 13 likes How much of the diluent volume the powder itself displaces: for a small peptide vial, the powder volume is negligible. For a larger vial or a kit with multiple…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #127 · Analytics › COA interpretation · 26 Mar 2025 · 0 likes What would change my mind on Counter-ion form is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would rather say…
-
Validating a method you did not develop — does this still hold? Replied, post #147 · Analytics › Method validation · 21 Mar 2025 · 20 likes One caution on Validating a method: everything above assumes the underlying documentation is what it claims to be. That assumption is doing real work and is rarely…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #8 · marked as the solution · Practice › Storage & stability · 20 Mar 2025 · 7 likes Narrowing post #7, because the general version has more than one answer. Adding what did not work for me on published stability data actually covers, since the failures…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #36 · Sourcing › Vendor reports · 16 Mar 2025 · 28 likes Report the certificate figure alongside the independent one. The comparison is the point and it is the part most often omitted.
-
Bleeding at the injection site: normal, and what to do about it — does this still hold? Replied, post #11 · Practice › Administration · 14 Mar 2025 · 0 likes Leaving the needle in for a couple of seconds after depressing the plunger reduces leakage at the site. It costs nothing and it is the fix for the "some came back out"…
-
State-level differences that actually matter Replied, post #2 · Regional › North America · 10 Mar 2025 · 4 likes Filing a mild objection to the consensus on state-level differences. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit.
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #25 · Practice › Reconstitution · 3 Mar 2025 · 15 likes Two sentences on 5 mg vial and then I will stop, because the rest is speculation and the thread is better without mine. What is documented is narrow. What is inferred…
-
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #12 · Compounds › Cagrilintide & amylin analogues · 21 Feb 2025 · 0 likes Is synergy the right word for the combination data? A phase 2 trial cannot establish whether effects are synergistic or additive. Synergy is a mechanistic claim that…
-
Revisiting: Filter needles: when they help and what they cost you Replied, post #2 · Devices › Syringes & needles · 19 Feb 2025 · 24 likes What I would want before treating Filter needles as settled: the method, the sample, and whether anyone tried to find the opposite result. Two of the three are usually…
-
Follow-up: Attributing a new peak: degradation product or excipient? Replied, post #7 · Analytics › Impurities & related substances · 15 Feb 2025 · 7 likes Two things can be true about Attributing a new peak at once: the mechanism is plausible and the evidence for the size of the effect is thin. Most of the argument here…
-
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #15 · Compounds › Retatrutide · 15 Feb 2025 · 0 likes Retatrutide is investigational. Anything obtained outside a trial is by definition research-use-only material with no human-use authorisation. This site will state that…
-
Consistent declarations and why they matter more than clever ones Replied, post #23 · Sourcing › Logistics · 12 Feb 2025 · 0 likes Border outcomes are not predictable at the level of an individual parcel. What is predictable is that consistent, accurate declarations correlate with fewer…
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #9 · Compounds › Semaglutide · 11 Feb 2025 · 0 likes On identity confirmation: a mass close to 4113.6 Da on the intact molecule is consistent with semaglutide and is also consistent with several closely related species.…
-
What a 2 ppm match establishes, and what it does not Started this topic · Analytics › Mass spectrometry · 10 Feb 2025 · 2 likes What a 2 ppm match establishes, and what it does not — that is the question, and I have not found it answered plainly anywhere I have looked. Working through the…
-
Scheduled maintenance and what will be unavailable Replied, post #26 · Meta › Announcements · 27 Jan 2025 · 11 likes Adding the boring version of scheduled maintenance, because the interesting version keeps getting posted and the boring one is usually right. Check the ordinary…
-
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #2 · Evidence › Meta-analyses · 24 Jan 2025 · 4 likes Answering the question the opening post raises rather than the one it answers. Fixed-effect and random-effects models answer different questions. The first assumes one…
-
Reporting a good result: why nobody bothers and why they should — one year on Replied, post #19 · Sourcing › Vendor reports · 3 Jan 2025 · 0 likes Photograph the vial and the label before opening. It costs ten seconds and it is what turns a report into something checkable. I am not the right person to answer the…
-
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #73 · Compounds › Semaglutide · 2 Jan 2025 · 2 likes On identity confirmation: a mass close to 4113.6 Da on the intact molecule is consistent with semaglutide and is also consistent with several closely related species.…
-
Coming back to: When to suspect the method rather than the sample Replied, post #95 · Analytics › Method validation · 18 Dec 2024 · 23 likes Specificity: the method can distinguish the intended compound from related impurities and degradation products. Tested by comparing results on pure compounds, mixtures…
-
Oxidation and deamidation mass shifts, tabulated Replied, post #20 · Analytics › Mass spectrometry · 15 Dec 2024 · 10 likes Appreciated. The plain phrasing does more work here than a longer post would.
-
Coming back to: When to suspect the method rather than the sample Replied, post #76 · Analytics › Method validation · 15 Dec 2024 · 7 likes Worth separating two things that post #74 runs together. A method that reports the same number for every lot is worth a second look. Real processes vary, and a total…
-
Body image changing more slowly than the body Replied, post #28 · Wellbeing › Mental health · 13 Dec 2024 · 0 likes Confirming post #27 from a second method, which matters more than confirming it from a second person. Motivation and expectation: starting with clear motivation and…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #21 · Devices › Cold chain · 13 Dec 2024 · 6 likes Temperature loggers in the parcel exist and are occasionally used for high-value shipments. They are the only thing that turns an argument about transit into a record.…
-
Why "any advice?" is the least effective ending for a post Replied, post #68 · Start Here › How to Ask · 24 Nov 2024 · 31 likes If the answer you got does not fit your case, say which part does not fit rather than restating the question. Otherwise the next reply is the same as the last one. The…
-
EMA product information as a primary source — does this still hold? Replied, post #142 · Regional › European Union · 18 Nov 2024 · 0 likes Before the thread moves on from EMA product information — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted from an…
-
Oxidation and deamidation mass shifts, tabulated Replied, post #2 · Analytics › Mass spectrometry · 31 Oct 2024 · 13 likes Monoisotopic and average mass are different numbers and both appear on documents. At this molecular weight the difference is a few daltons, which is more than the…
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #107 · Sourcing › Independent verification · 4 Oct 2024 · 12 likes Where I part company with post #105, and it is a narrow parting. Combining a chromatographic result with a documentation review gives a more complete picture than two…
-
US compounding rules and how they changed Replied, post #2 · Regional › North America · 25 Sep 2024 · 1 like Picking up the opening post: that is the part I would want checked first. Compounding pharmacies: pharmaceutical compounding of a drug not on the FDA shortage list is…
-
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #36 · Practice › Administration · 17 Sep 2024 · 0 likes If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life.
-
Hepatic effects of glucagon receptor agonism: the mechanistic worry Replied, post #19 · Compounds › Retatrutide · 5 Sep 2024 · 15 likes Post #18 put the caveat in the right place and I want to underline it. Second-hand on hepatic effects of glucagon receptor, so weight it accordingly — someone whose…
-
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #32 · Evidence › Journal club · 2 Sep 2024 · 0 likes The most common failure mode is spending fifty minutes on the effect size and ten on the population. Reversing that ratio would improve most sessions.
-
The C-cell question: rodent findings and their human context — what changed since Replied, post #27 · Compounds › Semaglutide · 29 Aug 2024 · 3 likes Noted, and thank you for writing it out rather than summarising it.
-
Circumference measurements as a poor man's composition estimate Replied, post #63 · Outcomes › Body composition · 13 Aug 2024 · 0 likes The arithmetic in post #62 is right; the assumption feeding it is the part to check. I would rather this thread reach "we do not know" about circumference measurements…